Precision Insights
Popular Insights
All Insights
Upcoming Webinar: A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
Power Your Commercial Decision Engines with PRECISIONxtract
If Data is the new oil, then you are dealing with Crude. Precision has the refinery to generate the enriched, high-octane gasoline you need to power your commercial decision engines.
PRECISIONxtract partners with Snowflake
PRECISIONxtract is very excited to share that we are partnering with Snowflake to place our Payer, Provider and Claims data products within their new marketplace, the Healthcare & Life Sciences Data Cloud.
Unlocking the Medical Payer Master
Over the past few years, pharmaceutical manufacturers have launched an increasing number of products covered under a health plan’s medical benefit. In response, health plans are exploring applying tools used successfully on the pharmacy benefit to the medical benefit.
MDM for Those Getting Started
Precision Master Data Management (MDM) software enables the critical steps of the mastering process to facilitate downstream analytics across the Drug, HCP, and Healthcare Organization (HCO) domains. This paper addresses some of the key challenges and highlights best practices for connecting datasets and creating a single source of truth in each respective domain.
Exploring the Mysterious PBM-GPO Model
As large pharmacy benefit managers (PBMs) create group purchasing organizations (GPOs) to manage the regulatory risk and transition to administrative fees as a source of revenue rather than manufacturer rebates, there is a lot of mystery surrounding the operation of these new entities.